Pr ecis: These findings reveal the mechanisms by which cancer cells but not T cells can compensate for tryptophan deprivation in a tumor microenvironment by upregulating the expression of amino acid transporters that mediate cellular tryptophan uptake.
6205

Snail1-Dependent Activation of Cancer-Associated Fibroblast Controls Epithelial Tumor Cell Invasion and Metastasis
Lorena Alba-Castellón, Rub en Olivera-Salguero, Aida Mestre-Farrera, Raúl Peña, Mercedes Herrera, F elix Bonilla, J. Ignacio Casal, Josep Baulida, Cristina Peña, and Antonio García de Herreros Pr ecis: Eliminating Snail1 function in tumor stromal fibroblasts prevent the invasive capacity of epithelial tumor cells.
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Interleukin-30 Promotes Breast Cancer Growth and Progression Pr ecis: These findings offer preclinical proof of concept for the potential utility of the chemokine CCL22, as delivered by local injection, to enhance the efficacious response of immune checkpoint therapy in melanoma patients while suppressing the autoimmune side-effects of the treatment.
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Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma Naomi Takahashi, Makoto Sugaya, Hiraku Suga, Tomonori Oka, Makiko Kawaguchi, Tomomitsu Miyagaki, Hideki Fujita, and Shinichi Sato Pr ecis: A growth-reinforcing cycle reported in atopic dermatitis also functions in cutaneous T-cell lymphoma, not only inducing a Th2-dominant tumor environment but also stimulating tumor cell proliferation in this malignancy. Pr ecis: This study identifies how a new oncogene in breast cancer is normally suppressed to prevent aberrant growth but becomes activated to promote cancer, with potential implications to understand and therapeutically exploit a critical interface between the WNT and Hippo signaling pathways that drive this disease.
MNX1 Is Oncogenically Upregulated in African-
American Prostate Cancer
Li Zhang, Jianghua Wang, Yongquan Wang, Yiqun Zhang, Patricia Castro, Longjiang Shao, Arun Sreekumar, Nagireddy Putluri, Nilanjan Guha, Saligrama Deepak, Arunkumar Padmanaban, Chad J. Creighton, and Michael Ittmann Pr ecis: An oncogene regulated by androgen and AKT is activated in prostate cancers relatively more frequently in African-American men, potentially offering a novel therapeutic target to address the increased incidence of aggressive disease in this patient population. 
ABOUT THE COVER
Upregulation of the stem cell reprogramming factor PBX1 mediates resistance to platinumbased chemotherapy in ovarian cancer. Using an in vitro dual-color competition assay, PBX1-positive cells were labeled green and PBX1-negative cells were labeled red. It was found that PBX1-positive cells escaped the cytotoxic effects from a platinum-based agent, carboplatin, much more efficiently than did PBX1-negative cells, as demonstrated by an increased green to red ratio at several days following carboplatin treatment. For details, see article by Jung and colleagues on page 6351. 
